Nano News

Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.

Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.

Discover case study data from scientists at UPenn demonstrating a label-free CAR T cytotoxicity assay, with high resolution CAR T cell images.

Mitochondrial stress can act as an early warning biomarker for drug candidate toxicity and can appear hours before conventional cell viability results. Discover case study data demonstrating how mitochondrial stress can be used as an early warning biomarker for cytotoxicity prediction.

We review recent peer-reviewed studies that relied on noninvasive live-cell imaging to study immuno-oncology, cellular metabolism and disease progression in 2025, and share how advances in image analysis are supporting consistent interpretation of complex live-cell data in preclinical research.

We look back at some of 2025’s major advances in AI-driven live cell analytics, from automated mitochondrial segmentation to dynamic EC50 profiling and next-generation T-cell insights. These breakthroughs bring deeper, label-free understanding to drug discovery and immuno-oncology.

With animal-testing bans in place, cosmetics R&D urgently needs reliable in vitro models that combine predictive power, reproducibility, and ethical compliance. Nanolive’s CRO services provide label-free, high-content live-cell analysis to assess ingredient safety, toxicity, and efficacy…

Phenotypic screening has re-emerged as a powerful approach for identifying and characterizing drug candidates, especially in an era where mechanism-based screening often overlooks complex biological responses…

Drug selectivity is essential for maximizing therapeutic efficacy while minimizing toxicity to healthy cells, a key driver of clinical success. Measuring drug effects on target cells alone often overlooks off-target toxicity that can deprioritize promising candidates…

Welcome to the August edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...

Welcome to the July edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...

Welcome to the June edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...